This chapter explores the historical development and therapeutic potential of MDMA, long considered a party drug. It discusses its role in couples therapy, particularly in supporting trauma recovery, and contrasts its effects with other psychedelics like psilocybin and ketamine. The conversation emphasizes the importance of connection fostered through MDMA-assisted therapy, the ongoing regulatory changes surrounding its use, and the hope it brings for innovative mental health treatments.
Could psychedelics revolutionize mental health care? Psychiatrist Dr. Will Van Derveer openingly discusses his exploration of psychedelic-assisted therapies after becoming disillusioned with conventional treatments.
He details remarkable results using ketamine, psilocybin, and MDMA for conditions like PTSD and depression. With the FDA's imminent decision on rescheduling MDMA, Van Derveer provides an inside look at these groundbreaking medicines' therapeutic potential. For those struggling with mental health issues, this candid conversation may reveal new hope.
You can find Will at: Website | Higher Practice Podcast | Episode Transcript
If you LOVED this episode you’ll also love the conversations we had with Adam Gazzaley about cutting-edge research he’s leading in this field.
Check out our offerings & partners:
Hosted on Acast. See acast.com/privacy for more information.